Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
8th grade Good
|
New words:
abstract, Aesgen, antiviral, assigned, assume, assumed, assurance, banking, building, calcitriol, cervical, commencing, committed, compound, comprise, conclusion, condensed, consumated, Coordinating, Dacogen, DacogenTM, decitabine, deductible, Delaware, draft, dysplasia, Emerging, enterprise, escalating, FAS, feasibility, focused, foreseeable, forma, frame, geographically, goodwill, HCl, immune, Infusion, intangible, intercompany, iterative, Jersey, lesser, Lexington, likelihood, maximum, MDS, merged, MGIP, minimal, Minimizing, module, myelodysplastic, ownership, pamidronate, path, placement, Princeton, pro, Pronouncement, realization, realize, remediation, resell, reserve, resold, SaforisTMoral, sublicensing, sulfate, SuperGen, surviving, tangible, Task, Tentative, unrestricted, wholly, workforce, ZYC
Removed:
activity, American, DNA, mechanism, methyltransferase, North, selected
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 3.4 Amendment Dated May 10, 2004 to Restated Bylaws
- 10.1 Amended and Restated License Agreement
- 10.2 the Common Stock Purchase Agreement
- 10.3 Investor Rights Agreement
- 31.1 Certification of CEO Pursuant to SS 302
- 31.2 Certification of CFO Pursuant to SS 302
- 32.1 Certification of CEO Pursuant to SS 906
- 32.2 Certification of CFO Pursuant to SS 906
Related press release
MOGN similar filings
Filing view
External links